Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Expands By 246.6%

Azitra, Inc. (NYSEAMERICAN:AZTR) was the target of a significant growth in short interest in the month of June. As of June 15th, there was short interest totaling 213,653 shares, a growth of 246.6% from the May 31st total of 61,636 shares. Based on an average daily volume of 333,674 shares, the short-interest ratio is currently 0.6 days. Currently, 1.3% of the company’s shares are sold short.

Azitra Stock Performance

Shares of AZTR stock opened at $0.17 on Friday. Azitra has a 12 month low of $0.10 and a 12 month high of $1.83. The firm’s 50 day moving average is $0.21 and its 200 day moving average is $0.23.

Azitra (NYSEAMERICAN:AZTR) last issued its quarterly earnings data on Wednesday, May 13th. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.24). On average, equities research analysts predict that Azitra will post -0.25 earnings per share for the current year.

Azitra Company Profile

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.